Projects per year
Personal profile
Biography
Alberta Hoi is the Head of the Lupus+ Clinical Research Hub at the School of Clinical Sciences Monash University. She is also an internationally renowned clinician, and serves as the Head of Monash Lupus Clinic, while also holding senior rheumatology positions at Monash Health and Austin Health. With over 25 years of clinical experience, Prof Alberta Hoi specialises in managing complex cases of systemic lupus erythematosus (SLE), Sjogren and Dermatomyositis.
Her academic career is centred on the clinical science of SLE and other autoimmune diseases. Her research focuses on identifying disease predictors, understanding comorbidities, and incorporating patient perspectives. She is the Chair of the Australian Lupus Registry & Biobank, and serves on the Executive Steering Committee of the Asia Pacific Lupus Collaboration (APLC). Additionally, she is actively involved in the Asia Pacific League Against Rheumatism (APLAR) Special Interest Groups for SLE and Sjogren, and investigators in the OMERACT working groups for defining core outcome sets in SLE and Sjogren clinical trials. She has a keen interest in transition care and optimising pregnancy in SLE patients.
Her work has been supported by grants from Arthritis Australia, Perpetual IMPACT philanthropy program, Medical Research Future Fund, and industry partners. She was the recipient of the Australian Rheumatology Association President Prize’s for Collaborative Research. She is Principal Investigator for multiple Phase 2/3 clinical trials in SLE and Sjogren’s Disease, including as the Australian rheumatology lead for the first CAR-T therapy trial.
In addition to her extensive publication record and collaborative research endeavours aimed at improving outcomes and bringing newer therapies for patients with autoimmune diseases, Prof Hoi is dedicated to mentoring and supervising undergraduate and postgraduate students in clinical research. Her leadership roles extend to serving as Treasurers of the Australian Rheumatology Association (2022-2024) and its Victorian branch (2015-2020) as well as Australian Chinese Medical Association of Victoria (2019), where she contributes to strategic planning, governance, and advocacy.
Education/Academic qualification
Immunology, PhD, MONASH UNIVERSITY
Award Date: 9 Dec 2010
Rheumatology, FRACP, Royal Australasian College of Physicians (RACP)
Award Date: 17 Dec 2003
Medicine & Surgery, MBBS, University of Melbourne
Award Date: 7 Dec 1996
External positions
Consultant Rheumatologist, Austin Health
2008 → …
Senior Consultant Rheumatologist, Department of Rheumatology, Austin Hospital
2008 → …
Director and principal rheumatologist, Eastern Rheumatology
2008 → …
VMO, Rheumatologist, Epworth Eastern Hospital
2008 → …
Consultant Rheumatologist, Monash Health
2003 → …
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Collaborations and top research areas from the last five years
-
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Parallel Study to Evaluate the Efficacy and Safety of Enpatoran in Participants with Active Cutaneous Manifestations of Lupus Erythematosus with or without Systemic Disease Receiving Standard of Care
Hoi, A. (Primary Chief Investigator (PCI))
5/07/26 → 4/07/31
Project: Research
-
Resetting plasma cells in autoimmunity for sustained remission
Ding, Z. (Primary Chief Investigator (PCI)), Hoi, A. (Chief Investigator (CI)), Yan, F. (Associate Investigator (AI)), Hibbs, M. (Associate Investigator (AI)), Tarlinton, D. (Associate Investigator (AI)), Morand, E. (Associate Investigator (AI)) & Yip, R. (Associate Investigator (AI))
1/01/26 → 31/12/29
Project: Research
-
-
A Phase 3 Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial with Open-Label Extension to Evaluate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 Subcutaneous Administered by Prefilled Syringe in Adult Patients with Primary Sjögren’s Disease
Hoi, A. (Primary Chief Investigator (PCI))
4/07/25 → 3/07/30
Project: Research
-
SELECT-SLE: A Phase 3 Program to Evaluate the Safety and Efficacy of Upadacitinib in Subjects with Moderately to Severely Active SLE
Hoi, A. (Primary Chief Investigator (PCI))
27/02/24 → 26/02/29
Project: Research
-
Prevalence, Treatment Patterns, and Outcomes Among Australian SLE Patients With Inadequately Controlled Disease Activity
Hoi, A. Y. B., Koelmeyer, R., Oon, S., Goldblatt, F., O'Neill, S., Golder, V., Nikpour, M., Morand, E. F. & Kandane-Rathnayake, R., Jan 2026, In: International Journal of Rheumatic Diseases. 29, 1, 5 p., e70549.Research output: Contribution to journal › Letter › Research › peer-review
-
Association of lupus low disease activity state and remission with reduced organ damage and flare in systemic lupus erythematosus patients with high disease activity: a multi-national, longitudinal cohort study
Kandane-Rathnayake, R., Golder, V., Louthrenoo, W., Chen, Y. H., Cho, J., Lateef, A., Hamijoyo, L., Luo, S. F., Wu, Y. J. J., Navarra, S. V., Zamora, L., Li, Z., Sockalingam, S., Katsumata, Y., Harigai, M., Hao, Y., Zhang, Z., Basnayake, B. M. D. B., Chan, M. & Kikuchi, J. & 18 others, , May 2025, In: Rheumatology. 64, 5, p. 2741-2748 8 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access7 Link opens in a new tab Citations (Scopus) -
Evaluation of primary aldosteronism testing in hypertensive patients with SLE in a tertiary hospital
Wong, M. (Leading Author), Hoi, A., Kent, J. R., Fuller, P., Yang, J. (Leading Author) & Vincent, F. B. (Leading Author), 18 Feb 2025, In: Lupus Science & Medicine. 12, 1, 3 p., e001524.Research output: Contribution to journal › Letter › Research › peer-review
Open Access -
Exploring CAR NK-cell therapy for refractory lupus
Hoi, A., 20 Dec 2025, In: The Lancet. 406, 10522, p. 2872-2874 3 p.Research output: Contribution to journal › Comment / Debate › Other › peer-review
-
Frequency and Determinants of Flare and Persistently Active Disease in a Large Multinational Prospective Lupus Cohort
Hao, Y., Hansen, D., Louthrenoo, W., Chen, Y. H., Cho, J., Lateef, A., Hamijoyo, L., Luo, S. F., Wu, Y. J., Navarra, S., Zamora, L., Li, Z., Sockalingam, S., Katsumata, Y., Harigai, M., Ji, L., Zhang, Z., Chan, M., Kikuchi, J. & Takeuchi, T. & 19 others, , Mar 2025, In: ACR Open Rheumatology. 7, 3, 9 p., e70007.Research output: Contribution to journal › Article › Research › peer-review
Open Access2 Link opens in a new tab Citations (Scopus)
Prizes
-
Australian Rheumatology Association President's Prize for Collaborative Research
Hoi, A. (Recipient), 2021
Prize: National/international honour
-
Press/Media
-
Disease Activity Measurement in Systemic Lupus Erythematosus
30/09/24
1 Media contribution
Press/Media: Profile/Interview
-
‘Mind-boggling’ wait times leave Victorians suffering for years before seeing specialists
18/12/22
1 Media contribution
Press/Media: Expert Comment
-